Clinical Trial

Treatment Options for Chronic Urticaria

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 10, 2025 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
chronic urticaria is one of the most common dermatological disease affecting many people, exploring most treatment options for its treatment is need of an hour. Our study aim to compare the efficacy of Autologous Serum Therapy (AST) with levocetirizine in Chronic Urticaria patients
Trial Details
NCT Number NCT06816784
Lead Sponsor Sheikh Zayed Medical College
Conditions Chronic Urticaria
Enrollment 72 participants
Start Date 2025-02
Primary Completion 2025-07 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2025-02-10